Showing results (301-310 of 314) with videos related to
Sort By:
Pageof 32
Annals of the Rheumatic Diseases|October 13, 2017
Recommendations for collaborative paediatric research including biobanking in Europe: a Single Hub and Access point for paediatric Rheumatology in Europe (SHARE) initiativeJasmin B Kuemmerle-Deschner, Sandra Hansmann, Nico M Wulffraat, et al.The International Journal on Drug Policy|November 2, 2018
Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapyJason Grebely, Brian Conway, Evan B Cunningham, et al.The International Journal on Drug Policy|October 24, 2018
Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY studyEvan B Cunningham, Janaki Amin, Jordan J Feld, et al.The Lancet. Gastroenterology & Hepatology|January 10, 2018
Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trialJason Grebely, Olav Dalgard, Brian Conway, et al.Journal of Hepatology|June 14, 2019
Sofosbuvir/velpatasvir for 12 weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysisSergio M Borgia, Janet Dearden, Eric M Yoshida, et al.PDA Journal of Pharmaceutical Science and Technology|April 20, 2018
Implementation of Plate Imaging for Demonstration of Monoclonality in Biologics Manufacturing DevelopmentKyle Zingaro, David Shaw, Jerry Carson, et al.Cell Reports. Medicine|June 2, 2022
SARS-CoV-2 Omicron variant escapes neutralizing antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescentsPablo Garcia-Valtanen, Christopher M Hope, Makutiro G Masavuli, et al.Journal of Medicinal Chemistry|December 11, 2012
3-Amido pyrrolopyrazine JAK kinase inhibitors: development of a JAK3 vs JAK1 selective inhibitor and evaluation in cellular and in vivo modelsMichael Soth, Johannes C Hermann, Calvin Yee, et al.Internal Medicine Journal|November 16, 2020
COVID-19 in Australia: our national response to the first cases of SARS-CoV-2 infection during the early biocontainment phaseRamon Z Shaban, Cecilia Li, Matthew V N O'Sullivan, et al.Open Forum Infectious Diseases|April 23, 2024
Hepatitis C Virus Antiviral Drug Resistance and Salvage Therapy Outcomes Across AustraliaDao Sen Wang, Amy Phu, Kristen McKee, et al.Pageof 32